282 results
Page 5 of 15
8-K
EX-10.1
8ibcki
20 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
8kln0jt4ln cabg
10 Nov 14
TG Therapeutics, Inc. Announces Third Quarter 2014 Financial Results and Business Update
12:00am
8-K
EX-99.1
qm3 j6b4yg
15 Sep 14
Overall Response Rate (ORR) to be the Primary Endpoint to Support Accelerated Approval with Progression-Free Survival (PFS) to Support Full Approval
12:00am
8-K
EX-99.1
triz290ny16j
21 Jul 14
TG Therapeutics, Inc. Announces Second Quarter 2014 Financial Results and Business Update
12:00am
8-K
EX-4.1
6d325w8 x3fcfi4d
21 Jul 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
ml5ocw5cc65xd12ryi0
21 Jul 14
Other Events
12:00am
8-A12B
EX-1
wxk05drcbfafg35vv
21 Jul 14
Registration of securities on exchange
12:00am
8-K
EX-99.1
kdu6g
30 May 14
TG Therapeutics, Inc. Announces Presentation of Single Agent Data for Both TG-1101 and TGR-1202 in Ongoing Phase I Clinical Studies
12:00am
8-K
EX-99.1
xeppb
12 Mar 14
Financial Statements and Exhibits
12:00am
8-K
EX-99.1
fycm cul50i
18 Jul 13
Financial Statements and Exhibits
12:00am
8-K
EX-10.1
gz5v d87y
21 Jun 13
Entry into a Material Definitive Agreement
12:00am